| 2026-01-09 | -45.6% | news | Investing.com | Beta Bionics stock tumbles following deceleration in new patient starts - Investing.com |
| 2026-01-09 | -45.6% | earnings | Investing.com | Beta Bionics stock to exceed Q4 revenue targets, Stifel maintains Buy - Investing.com |
| 2026-01-08 | -36.7% | earnings | Seeking Alpha | Beta Bionics reports Strong Preliminary Q4 2025 Topline Growth |
| 2026-01-08 | -36.7% | news | Stock Titan | Diabetes device maker doubles its user base as thousands quit injections - Stock Titan |
| 2025-05-06 | +23.4% | earnings | Seeking Alpha | Beta Bionics GAAP EPS of -$0.93 misses by $0.46, revenue of $17.6M beats by $1.45M |
| 2025-09-08 | +23.3% | news | Seeking Alpha | Beta Bionics, Inc. (BBNX) Presents At Morgan Stanley 23rd Annual Global Healthcare Conference Transcript |
| 2026-04-14 | +20.5% | news | TradingView | BBNX Options Chain — NASDAQ:BBNX - TradingView |
| 2026-04-14 | +20.5% | earnings | MarketBeat | Beta Bionics (NASDAQ:BBNX) Trading Up 8.3% - What's Next? - MarketBeat |
| 2026-04-14 | +20.5% | news | TradingView | BBNX Options Volatility — NASDAQ:BBNX - TradingView |
| 2025-07-29 | +20.2% | earnings | Seeking Alpha | Beta Bionics GAAP EPS of -$0.39 beats by $0.08, revenue of $23.2M beats by $3.51M |
| 2025-07-29 | +20.2% | earnings | Drug Delivery Business | Beta Bionics stock gets a boost on Q2 results, raised guidance - Drug Delivery Business |
| 2025-09-05 | +15.1% | news | Seeking Alpha | Beta Bionics: Guiding Conservative After All |
| 2025-06-23 | -14.2% | M&A | Yahoo Finance | BBNX Stock May Gain From Abbott Deal to Advance iLet Integration - Yahoo Finance |
| 2026-01-12 | -14.2% | legal | marketscreener.com | Securities Fraud Investigation Into Beta Bionics, Inc. (BBNX) Announced – Investors Who Lost Money Urged To Contact The Law Offices of Frank R. Cruz - marketscreener.com |
| 2026-01-12 | -14.2% | news | Business Wire | INVESTOR ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Beta Bionics - Business Wire |
| 2026-02-09 | +12.8% | analyst | Investing.com | UBS initiates coverage on Beta Bionics stock with Buy rating - Investing.com |
| 2026-01-10 | -12.5% | earnings | Trefis | Beta Bionics Stock (-37%): Patient Growth Miss Spooks Street - Trefis |
| 2026-01-10 | -12.5% | earnings | simplywall.st | Does Beta Bionics (BBNX) Strong Q4 Sales Outlook Reshape Confidence in Its Long-Term Strategy? - simplywall.st |
| 2025-10-28 | +12.5% | earnings | Seeking Alpha | Beta Bionics GAAP EPS of -$0.33 beats by $0.09, revenue of $27.3M beats by $3.32M |
| 2025-10-28 | +12.5% | earnings | Drug Delivery Business | Beta Bionics stock rises on Q3 beats, raised full-year guidance, advances iLet offerings - Drug Delivery Business |
| 2025-10-28 | +12.5% | earnings | Yahoo Finance | Beta Bionics, Inc. (BBNX) Reports Q3 Earnings: What Key Metrics Have to Say - Yahoo Finance |
| 2025-10-29 | +11.3% | earnings | Seeking Alpha | Beta Bionics raises 2025 revenue guidance to $96.5M and projects Q4 gross margin improvement amid pharmacy channel expansion |
| 2025-10-29 | +11.3% | earnings | Seeking Alpha | Beta Bionics, Inc. (BBNX) Q3 2025 Earnings Call Transcript |
| 2025-03-25 | -10.5% | earnings | Seeking Alpha | Beta Bionics GAAP EPS of -$2.72 misses by $1.63, revenue of $20.44M beats by $0.25M |
| 2026-04-10 | +9.5% | news | Xã Thanh Hà | Are executives confident in Beta Bionics (BBNX) Stock | Price at $9.25, Down 3.95% - Expert Breakout Alerts - Xã Thanh Hà |
| 2026-03-30 | -9.4% | earnings | Stock Titan | Beta Bionics to discuss Q1 results April 21 after market close - Stock Titan |
| 2026-03-30 | -9.4% | earnings | MarketBeat | Beta Bionics, Inc. (NASDAQ:BBNX) Short Interest Update - MarketBeat |
| 2026-04-23 | -8.8% | news | GlobeNewswire | Global Automated Insulin Delivery System Market Size/Share Worth USD 2684 Million by 2035 at a 10.5% CAGR: Healthcare Foresights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth Rate, SWOT Analysis) |
| 2026-04-23 | -8.8% | earnings | Cổng thông tin điện tử tỉnh Tây Ninh | BBNX (Beta Bionics Inc.) posts narrower Q4 2025 loss than consensus estimates, sending shares up more than six percent. - Analyst Recommended Stocks - Cổng thông tin điện tử tỉnh Tây Ninh |
| 2026-04-23 | -8.8% | analyst | The Globe and Mail | Analysts’ Opinions Are Mixed on These Healthcare Stocks: Beta Bionics, Inc. (BBNX) and Danaher (DHR) - The Globe and Mail |
| 2026-01-30 | -7.6% | legal | Stock Titan | FDA warning letter hits Beta Bionics (NASDAQ: BBNX) but Mint plan stands - Stock Titan |
| 2026-04-22 | -7.5% | earnings | Moby | Beta Bionics, Inc. Q1 2026 Earnings Call Summary |
| 2026-04-22 | -7.5% | earnings | GuruFocus.com | Beta Bionics Inc (BBNX) Q1 2026 Earnings Call Highlights: Strong Sales Growth Amid Operational ... |
| 2026-04-22 | -7.5% | earnings | Seeking Alpha | Beta Bionics projects $131M-$136M 2026 revenue and raises gross margin outlook to 57.5%-59.5% |
| 2026-04-22 | -7.5% | earnings | Seeking Alpha | Beta Bionics, Inc. 2026 Q1 - Results - Earnings Call Presentation |
| 2026-04-22 | -7.5% | earnings | Seeking Alpha | Beta Bionics, Inc. (BBNX) Q1 2026 Earnings Call Transcript |
| 2026-04-22 | -7.5% | earnings | Seeking Alpha | Beta Bionics, Inc. 2026 Q1 - Results - Earnings Call Presentation (NASDAQ:BBNX) 2026-04-21 - Seeking Alpha |
| 2026-04-22 | -7.5% | earnings | Investing.com India | Wolfe Research cuts Beta Bionics stock price target on guidance By Investing.com - Investing.com India |
| 2026-01-26 | -7.4% | legal | GlobeNewswire | INVESTOR ALERT: Investigation of Beta Bionics, Inc. (BBNX) by Holzer & Holzer, LLC - GlobeNewswire |
| 2026-03-13 | +7.1% | news | Seeking Alpha | Beta Bionics: Speculative Appeal After An Eventful Start To The Year |
| 2026-03-13 | +7.1% | news | Seeking Alpha | Beta Bionics - Speculative Appeal After An Eventful Start To The Year (NASDAQ:BBNX) - Seeking Alpha |
| 2026-04-21 | -5.9% | earnings | MarketBeat | Beta Bionics Q1 Earnings Call Highlights |
| 2026-04-21 | -5.9% | earnings | Motley Fool | Beta Bionics BBNX Q1 2026 Earnings Transcript |
| 2026-04-21 | -5.9% | earnings | MT Newswires | Beta Bionics Q1 Loss Narrows, Revenue Rises; Raises Full-Year 2026 Revenue Guidance |
| 2026-04-21 | -5.9% | earnings | Zacks | Beta Bionics, Inc. (BBNX) Reports Q1 Loss, Misses Revenue Estimates |
| 2026-04-21 | -5.9% | earnings | GlobeNewswire | Beta Bionics Announces First Quarter 2026 Financial Results and Raises Full Year 2026 Guidance |
| 2026-04-21 | -5.9% | earnings | Seeking Alpha | Beta Bionics GAAP EPS of -$0.49 beats by $0.01, revenue of $27.6M beats by $0.63M |
| 2026-04-21 | -5.9% | earnings | Quiver Quantitative | Beta Bionics Inc. (BBNX) Stock Rises on Q1 2026 Earnings - Quiver Quantitative |
| 2026-04-21 | -5.9% | news | Stock Titan | Diabetes tech maker Beta Bionics lifts outlook after 57% sales jump - Stock Titan |
| 2026-04-21 | -5.9% | earnings | Stock Titan | Surging Q1 sales lead Beta Bionics (NASDAQ: BBNX) to lift 2026 guidance - Stock Titan |
| 2026-04-21 | -5.9% | earnings | Stock Titan | Beta Bionics (BBNX) grows iLet sales to $27.6M while narrowing quarterly loss - Stock Titan |
| 2025-10-16 | -5.1% | analyst | Yahoo Finance | Goldman Sachs Upgrades Beta Bionics (BBNX) to Buy, Raises PT to $26 on Strong Growth and Market Outlook - Yahoo Finance |
| 2026-02-02 | +4.9% | analyst | Investing.com | TD Cowen reiterates Hold rating on Beta Bionics stock amid FDA warning letter - Investing.com |
| 2026-02-02 | +4.9% | analyst | Investing.com | Truist Securities lowers Beta Bionics stock price target to $25 from $37 - Investing.com |
| 2026-04-20 | -4.6% | earnings | GuruFocus.com | Beta Bionics Inc (BBNX) Q1 2026 Earnings Report Preview: What To Expect |
| 2026-04-08 | -4.2% | news | Cổng thông tin điện tử tỉnh Tây Ninh | Is Beta Bionics (BBNX) Stock Attractive Now | Price at $9.82, Up 0.92% - Micro Trends - Cổng thông tin điện tử tỉnh Tây Ninh |
| 2026-03-04 | -4.1% | news | Stock Titan | Sean Saint to sell 3,384 Beta Bionics shares (BBNX) via Morgan Stanley - Stock Titan |
| 2026-02-18 | -3.9% | earnings | Seeking Alpha | Beta Bionics, Inc. 2025 Q4 - Results - Earnings Call Presentation |
| 2026-02-18 | -3.9% | earnings | Seeking Alpha | Beta Bionics outlines $130M–$135M 2026 revenue target while expanding sales force and pharmacy channel |
| 2026-02-18 | -3.9% | earnings | Seeking Alpha | Beta Bionics, Inc. (BBNX) Q4 2025 Earnings Call Transcript |
| 2026-02-18 | -3.9% | earnings | Investing.com | TD Cowen cuts Beta Bionics stock price target on revenue timing - Investing.com |
| 2025-02-02 | -3.8% | news | Seeking Alpha | Beta Bionics: A Sugar Rush For This IPO |
| 2025-02-07 | -3.8% | news | Zacks Investment Research | Should I buy Beta Bionics, Inc. (BBNX) - Zacks Investment Research |
| 2025-02-07 | -3.8% | news | ChartMill | BBNX Stock Price, Quote & Chart | BETA BIONICS INC (NASDAQ:BBNX) - ChartMill |
| 2025-02-07 | -3.8% | news | CoinCodex | Beta Bionics, Inc. Common Stock (BBNX) Stock Forecast & Price Prediction 2026–2030 - CoinCodex |
| 2026-01-22 | -3.7% | legal | The Globe and Mail | Kaplan Fox Reminds Investors of Beta Bionics, Inc. (BBNX) to an Investigation of Potential Securities Law Violations - The Globe and Mail |
| 2025-12-04 | -3.6% | news | Investing.com | Feider Stephen (Beta Bionics) sells $41,862 in shares - Investing.com |
| 2025-02-20 | -3.6% | news | Seeking Alpha | Beta Bionics rated new Neutral at Baird on valuation |
| 2025-02-03 | -3.4% | news | CNN | symbol__ Stock Quote Price and Forecast - CNN |
| 2026-01-14 | +3.2% | legal | NewMediaWire | Kaplan Fox Announces an Investigation Into Beta Bionics, Inc. (BBNX) for Potential Securities Law Violations - NewMediaWire |
| 2026-01-13 | -3.0% | news | Investing.com | Beta Bionics shares plunge 43% after InvestingPro’s overvalued warning By Investing.com - Investing.com |
| 2026-02-25 | -3.0% | earnings | Seeking Alpha | Lowest Quant ranked small-cap stocks with positive EPS surprises |
| 2026-02-25 | -3.0% | legal | GlobeNewswire | Beta Bionics, Inc. ALERT: Securities Fraud Investigation by Block & Leviton Could Allow Investors to Recover Losses - GlobeNewswire |
| 2026-02-25 | -3.0% | earnings | Seeking Alpha | Lowest Quant ranked small cap stocks with positive EPS surprises (BBNX:NASDAQ) - Seeking Alpha |
| 2026-02-17 | -3.0% | earnings | Seeking Alpha | Beta Bionics GAAP EPS of -$0.30 beats by $0.10, revenue of $32.1M beats by $1.03M |
| 2026-02-17 | -3.0% | earnings | Yahoo Finance | Beta Bionics, Inc. (BBNX) Reports Q4 Loss, Tops Revenue Estimates - Yahoo Finance |
| 2026-02-17 | -3.0% | news | Stock Titan | Diabetes device maker Beta Bionics passes $100M sales, targets up to $135M - Stock Titan |
| 2025-10-01 | +2.7% | analyst | Seeking Alpha | Doximity, LivaNova downgraded as Goldman Sachs reviews MedTech and Health IT coverage |
| 2025-12-09 | +2.5% | news | Seeking Alpha | Beta Bionics: It Has Been An Interesting Year |
| 2025-12-09 | +2.5% | news | Seeking Alpha | Beta Bionics: It Has Been An Interesting Year (NASDAQ:BBNX) - Seeking Alpha |
| 2026-04-06 | -2.5% | news | Cổng thông tin điện tử tỉnh Lào Cai | Is Beta Bionics (BBNX) Stock Discounted Now | Price at $9.97, Up 0.40% - Continuation Pattern - Cổng thông tin điện tử tỉnh Lào Cai |
| 2025-01-31 | -2.5% | news | TradingView | BBNX Stock Price and Chart — NASDAQ:BBNX - TradingView |
| 2025-01-31 | -2.5% | earnings | MarketBeat | Beta Bionics (BBNX) Stock Price, News & Analysis - MarketBeat |
| 2025-01-31 | -2.5% | earnings | MarketBeat | Beta Bionics (BBNX) Stock Forecast and Price Target 2026 - MarketBeat |
| 2025-10-30 | +2.4% | news | Moomoo | Beta Bionics, Inc. (NASDAQ:BBNX) Stocks Shoot Up 35% But Its P/S Still Looks Reasonable - Moomoo |
| 2026-02-06 | +2.3% | news | simplywall.st | Beta Bionics, Inc.'s (NASDAQ:BBNX) Popularity With Investors Under Threat As Stock Sinks 58% - simplywall.st |
| 2026-03-31 | -2.2% | earnings | Stock Titan | New diabetes report tool flags missed meals, insulin pauses - Stock Titan |
| 2025-02-11 | -2.2% | analyst | Zacks Investment Research | What is the current Price Target and Forecast for Beta Bionics, Inc. (BBNX) - Zacks Investment Research |
| 2026-04-15 | +2.1% | news | Cổng thông tin điện tử tỉnh Tây Ninh | Beta Bionics (BBNX) Stock: Worthwhile Investment? (+10.25%) 2026-04-15 - Most Discussed Stocks - Cổng thông tin điện tử tỉnh Tây Ninh |
| 2025-04-24 | +1.9% | news | Seeking Alpha | Beta Bionics: Slowing Down Or Being Conservative? |
| 2026-04-16 | -1.8% | news | Zacks | Beta Bionics, Inc. (BBNX) Soars 10.3%: Is Further Upside Left in the Stock? |
| 2026-03-06 | -1.7% | expansion | Business Wire | BBNX INVESTOR NOTICE: Faruqi & Faruqi, LLP Launches Investigation into Beta Bionics - Business Wire |
| 2025-05-10 | -1.7% | earnings | Seeking Alpha | Beta Bionics, Inc. (BBNX) Q1 2025 Earnings Call Transcript |
| 2025-11-02 | +1.6% | news | simplywall.st | Assessing Beta Bionics (BBNX) Valuation After Strong Run-Up in Share Price - simplywall.st |
| 2026-03-26 | -1.4% | news | Stock Titan | [SCHEDULE 13G/A] Beta Bionics, Inc. Amended Passive Investment Disclosure - Stock Titan |
| 2025-12-08 | -0.9% | earnings | Stock Titan | Beta Bionics (Nasdaq: BBNX) to pre-release Q4 2025 topline results week of Jan. 5 - Stock Titan |
| 2025-12-08 | -0.9% | news | simplywall.st | This Beta Bionics Insider Increased Their Holding By 130% Last Year - simplywall.st |
| 2026-04-19 | -0.3% | news | Seeking Alpha | Quant snapshot: Eni, Alpine Income Property Trust lead top-rated names as Crown Castle, Goosehead Insurance lag |
| 2025-07-31 | -0.1% | earnings | Seeking Alpha | Beta Bionics, Inc. 2025 Q2 - Results - Earnings Call Presentation |
| 2025-07-31 | -0.1% | earnings | Seeking Alpha | Beta Bionics, Inc. (BBNX) Q2 2025 Earnings Call Transcript |
| 2026-04-26 | — | news | MSN | Beta Bionics, Inc. (BBNX) soars 10.3%: Is further upside left in the stock? - MSN |
| 2026-04-25 | — | earnings | Intellectia AI | BBNX.O Stock News Today | Earnings, Events & Price Alerts - Intellectia AI |
| 2025-01-30 | — | news | Seeking Alpha | Artificial pancreas maker Beta Bionics aims to raise $204M in Nasdaq IPO |
| 2025-01-30 | — | news | Boston University | Bionic Pancreas Company Cofounded by BU Researcher Hits the Nasdaq Stock Market | The Brink - Boston University |
| 2025-01-30 | — | news | Drug Delivery Business | Beta Bionics goes public with upsized $234.6M IPO - Drug Delivery Business |
| 2025-01-30 | — | news | Investing.com | Beta Bionics stock opens 29% higher in Nasdaq debut - Investing.com |